STZ · DEEP VALUE BRIEFING

CONSTELLATION BRANDS, INC. (STZ)

published May 28, 2026 · price now $112.96 · market cap $19.7B

WATCH · low confidence — the research’s call on buying at the price it saw, not advice to you.

Information only, not investment advice. Written by AI research agents from SEC filings and market data, and it can be wrong. Check the model below before relying on any of it.

Executive Summary

STZ remains a WATCH. The beer franchise is clearly high quality and likely the source of most intrinsic value, but Buffett-style risk comes from the whole business, not just the best asset. At $142, ~14.8x earnings, and ~7.3% FCF yield, valuation is interesting enough to prevent an AVOID, yet not cheap enough to overcome slowing growth, weaker wine/spirits assets, and uncertain total-company quality. The best action is active monitoring or a very small starter only for tolerant investors, not full advocacy.


Key Arguments From Each Analyst

1. Risky Analyst — strongest bullish points

  • Core beer assets are real moat assets: Modelo, Corona, and Pacifico have shelf-space power, brand loyalty, and pricing strength.
  • Valuation has reset meaningfully: at 14.8x P/E and 7.3% FCF yield, the stock no longer requires perfection.
  • Cash generation and profitability remain solid: 51.6% gross margin, 20.9% ROE, 11.0% ROIC suggest this is not a broken business.
  • Opportunity exists because the story is messy: if beer stays strong and weaker segments merely stop worsening, rerating could occur before “clarity” arrives.

2. Safe Analyst — strongest bearish/cautious points

  • You own the whole company, not just the beer jewel: weaker wine and spirits still dilute predictability and quality.
  • Lower multiple may be deserved: slower or negative growth can indicate a narrower moat, fading category tailwinds, or weaker normalized earnings power.
  • Historical quality metrics do not fully protect forward returns: margins and ROE are backward-looking if future volume/mix worsen.
  • Technical weakness may reflect justified skepticism: repeated failed recoveries can signal that fundamentals are not yet trusted.

3. Neutral Analyst — strongest balancing points

  • The discount is meaningful, but not extreme enough to erase execution risk.
  • The Safe case may demand too much certainty and risk “waiting for comfort at a higher price.”
  • Best middle ground is conditional accumulation, not aggressive buying and not passive inaction.
  • STZ is investable, but only with staged sizing, because the core franchise is strong while the total-company story remains mixed.

Rationale

From a Buffett-style risk perspective, the central question is not whether STZ’s stock has fallen a lot. It is whether the business is durable, understandable, financially sound, and available at a sufficient discount to intrinsic value.

Why STZ stays out of AVOID

The bullish evidence is real:

  • Premium beer brands with durable consumer relevance
  • Gross margin of 51.6%
  • ROE of 20.9%
  • ROIC of 11.0%
  • FCF yield of 7.3%
  • No sign from the handoff that this is a balance-sheet or cash-flow stress story

Those facts matter. They support the view that this is not a broken business and likely not a classic value trap. That is important because Buffett risk is permanent impairment, and the beer franchise does not look permanently impaired from the evidence provided.

Why it does not rise to ADVOCATE

The caution is also valid:

  • The moat appears concentrated in beer, not broad across the enterprise
  • Wine and spirits weaken the blended quality
  • Growth has slowed or turned negative, which matters because predictability is falling
  • The valuation is reasonable, but not such a deep bargain that it clearly creates a wide margin of safety

A Buffett-style purchase usually becomes compelling when:

  1. business quality is evident across the whole company,
  2. cash flows are durable and predictable,
  3. management’s capital allocation supports per-share value creation,
  4. the stock is clearly below conservative intrinsic value.

STZ only partially clears that bar today.

Counterarguments addressed

  • Risky Analyst is right that waiting for perfect proof can miss upside. That lesson from the Adobe review is important: do not let long-term uncertainty fully override a valid valuation reset.
  • But the Adobe lesson should not be overapplied. Adobe had clearer “high-quality whole-business” characteristics. Here, the mixed-company issue is more fundamental, not merely sentiment-driven.
  • The Berkshire lesson is also useful: when a high-quality business is near fair value and stabilizing, the right answer can be watch-to-accumulate, not static passivity. That supports being less rigid than a pure sidelines stance.
  • Still, STZ is not Berkshire-like in total-company consistency. So the upgrade should be modest, not a jump to full advocacy.

The most accurate conclusion is:

good business, excellent segment, mixed enterprise, fair-to-interesting valuation, not enough margin of safety for conviction.

Refined Investor Plan

Starting from your original plan, I would keep the overall stance as WATCH, but refine it to be more active and less passive:

Updated plan

  • Base stance: WATCH
  • Implementation: acceptable as a small, staged starter position only, not a full allocation
  • Do not treat $142 as a screaming bargain
  • Do not ignore it either, because some pessimism is already reflected

What changed from the original plan

Your original conclusion was directionally strong: the bull wins on segment quality, the bear wins on total-company quality and margin of safety. I agree.

The adjustment, based on prior mistakes, is this:

  • Avoid “analysis says attractive, conclusion says do nothing.”
  • Separate business quality judgment from entry/tactical judgment.
  • That means STZ can remain a WATCH while still being a candidate for light accumulation, if an investor is disciplined and position sizes conservatively.

So the refined plan is:

For conservative long-term investors

  • Wait for more proof
  • Require evidence that:
  • beer depletion trends remain resilient,
  • wine/spirits drag is stabilizing or shrinking,
  • free cash flow remains durable,
  • management is improving portfolio quality or capital allocation

For moderate-risk long-term investors

  • Consider a small starter position
  • Add only if operating evidence improves
  • Keep size limited until the whole-company thesis strengthens

For aggressive investors

  • Acknowledge there is asymmetry here, but it is not yet Buffett-grade conviction
  • Any accumulation should still be staged, not all-at-once

Monitoring Priorities: Next 1 to 4 Quarters

Focus on what changes intrinsic value confidence, not just stock noise:

  1. Beer depletion and shipment trends
  • Modelo, Corona, Pacifico
  • Need evidence the core franchise remains resilient, not just “less bad”
  1. Consolidated organic sales and operating income
  • Is beer still carrying the company?
  • Are wine and spirits stabilizing or continuing to erode quality?
  1. Free cash flow conversion
  • Confirm that the 7.3% FCF yield is durable, not temporary
  1. Capital allocation and leverage
  • Debt reduction, buybacks, divestitures, portfolio simplification
  • Buffett-style confidence rises if management improves enterprise quality
  1. Margin trend
  • Gross and operating margins
  • Need to know whether pricing power is real or just masking softer volumes
  1. Guidance credibility
  • Repeated cuts would weaken the thesis that bad news is already priced in

Lessons Applied From Past Mistakes

From Adobe

  • Do not let unresolved long-term uncertainty automatically force a neutral stance if valuation is already depressed and fundamentals remain sound.
  • Applied here: STZ deserves more than a dismissive watchlist slot. It deserves active monitoring and potentially a small toe-hold.

From Berkshire

  • Fair value plus quality plus stabilization can justify “watch to accumulate,” not pure inactivity.
  • Applied here: if STZ shows support in fundamentals, accumulation can be rational even before all uncertainty clears.

Important distinction

Unlike Adobe, STZ’s issue is not just sentiment vs intact business quality. Unlike Berkshire, STZ does not have uniformly elite whole-company quality. That is why the final stance remains WATCH, not ADVOCATE.


Final Stance

WATCH

The model

Every input behind the value range, so you can check the work or change an assumption and redo it yourself. Computed deterministically from SEC filings (fiscal 2026), updated Oct 4, 2026; the market price was $112.96. Values are estimates, not predictions.

Owner earnings (Buffett)

Discounts owner earnings: the cash the business generates for its owners after the spending needed to keep it running.

Value per share: $84.11 / $113.79 / $662.83 (conservative / base / optimistic)

Starting Owner Earnings$1.2B
Growth: conservative / base / optimistic (2012–2026)-1.3% / 7.0% / 60.0%
Projection10 years
Discount rate10.0%
Terminal growth2.5%
Shares outstanding174M
The history the growth rates come from (15 years)
2012$480M
2013$441M
2014$1.9B
2015$322M
2016$385M
2017$869M
2018$1.5B
2019$2.9B
2020−$406M
2021$1.4B
2022−$725M
2023−$719M
2024$888M
2025−$848M
2026$1.2B

Free cash flow

Discounts reported free cash flow: operating cash flow minus capital expenditure.

Value per share: $84.71 / $164.71 / $405.60 (conservative / base / optimistic)

Starting Free Cash Flow$1.8B
Growth: conservative / base / optimistic (2012–2026)-11.0% / 6.8% / 32.7%
Projection10 years
Discount rate10.0%
Terminal growth2.5%
Shares outstanding174M
The history the growth rates come from (15 years)
2012$716M
2013$494M
2014$603M
2015$362M
2016$522M
2017$789M
2018$874M
2019$1.4B
2020$1.8B
2021$1.9B
2022$1.7B
2023$1.7B
2024$1.5B
2025$1.9B
2026$1.8B

Two-stage FCFF (Damodaran)

Projects revenue, operating margin and reinvestment, then discounts free cash flow to the firm at the weighted cost of capital.

Value per share: $85.10 / $171.37 / $184.82 (conservative / base / optimistic)

Starting Damodaran FCFF$2.0B
Growth: conservative / base / optimistic (2012–2026)2.6% / 8.3% / 8.3%
Projection10 years
Risk-free rate5.28%
Equity risk premium4.15%
Beta1.00
Cost of equity9.43%
After-tax cost of debt2.52%
Equity weight68%
WACC (discount rate)7.24%
Target operating margin (base)29.7%
High-growth stage5 years
Terminal growth2.5%
Shares outstanding174M

This briefing is from May 28, 2026. A fresh one re-reads the latest filings and prices; running it takes a free account.

Run a fresh briefing →Watch the video briefingGet the iPhone app

The Monday letter

One email a week: what great value investors bought and sold, and what we make of it.

Send me the DeepValues Monday letter, one email a week. I can unsubscribe at any time. Information only, not investment advice. Privacy